Cell Source, Inc. is a biotechnology company, which focuses on developing cell therapy treatments based on the management of immune tolerance. The company is headquartered in New York City, New York. The company went IPO on 2014-01-14. The firm is primarily focused on the development of immune system management technology (Veto Cell technology). Its lead prospective product is its Veto Cell immune system management technology. Its Veto Cell technology is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is in pre-clinical phase, and its data shows that it provides results in allogeneic (donor-derived) hematopoietic stem cell transplantation (HSCT) by allowing for haploidentical stem cell transplants under a mild conditioning regimen. Its product pipeline includes chimeric antigen receptor (CAR) T-cell therapies, which include VETO CAR-T (with or without HSCT) for B-cell malignancies, Veto Cell kidney transplants, VETO CAR-T for solid tumors, Veto Cell liver transplants, and Veto HSCT for non-malignant disorders. The firm's wholly owned subsidiary is Cell Source Limited (CSL).
Follow-Up Questions
Quel est le ratio P/E de Cell Source Inc (CLCS) ?
Le ratio P/E de Cell Source Inc est de N/A
Qui est le CEO de Cell Source Inc ?
Mr. Itamar Shimrat est le Chief Executive Officer de Cell Source Inc, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action CLCS ?
Le prix actuel de CLCS est de 0.44, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Cell Source Inc ?
Cell Source Inc appartient à l'industrie Biotechnology et le secteur est Health Care
Quelle est la capitalisation boursière de Cell Source Inc ?
La capitalisation boursière actuelle de Cell Source Inc est de $17.6
Est-ce que Cell Source Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 0 analystes ont établi des notations d'analystes pour Cell Source Inc, y compris 0 achat fort, 0 achat, 0 maintien, 0 vente et 0 vente forte
